Quantum BioPharma Ltd. (QNTM) Financials
QNTM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 14.4 million | 8.3 million |
| March 31, 2026 | 15.0 million | 16.4 million |
| Dec. 31, 2025 | 11.1 million | 6.0 million |
| Sept. 30, 2025 | 14.2 million | 6.6 million |
QNTM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.7 million | ? |
| March 31, 2026 | -1.6 million | 892057 |
| Dec. 31, 2025 | -305598 | 808452 |
| Sept. 30, 2025 | -1.7 million | 996194 |
QNTM Net Income
No data available :(
QNTM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 9.7 million | - | - |
| March 31, 2026 | 10.1 million | - | 83991 |
| Dec. 31, 2025 | 6.2 million | - | 103165 |
| Sept. 30, 2025 | 1.1 million | - | 151798 |
QNTM Shares Outstanding
QNTM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 3 | 377589 | 1.7 million | - |
| March 31, 2026 | 3 | 617419 | 2.1 million | - |
| Dec. 31, 2025 | - | 70404 | 2.2 million | - |
| Sept. 30, 2025 | - | 495223 | 4.0 million | - |
QNTM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 125108 |
| March 31, 2026 | - | 125670 |
| Dec. 31, 2025 | - | 131359 |
| Sept. 30, 2025 | - | 143724 |
QNTM
Price: $2.43
52 week price:
Earnings Per Share: -7.73 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 19.8 million